Premium
Positron emission tomography molecular imaging‐based cancer phenotyping
Author(s) -
Jin Chentao,
Luo Xiaoyun,
Li Xiaoyi,
Zhou Rui,
Zhong Yan,
Xu Zhoujiao,
Cui Chunyi,
Xing Xiaoqing,
Zhang Hong,
Tian Mei
Publication year - 2022
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.34228
Subject(s) - positron emission tomography , cancer , medicine , cancer imaging , preclinical imaging , molecular imaging , pet imaging , medical physics , cancer detection , in vivo , nuclear medicine , biology , microbiology and biotechnology
During the past several decades, numerous studies have provided insights into biological characteristics of cancer cells and identified various hallmarks of cancer acquired in the tumorigenic processes. However, it is still challenging to image these distinctive traits of cancer to facilitate the management of patients in clinical settings. The rapidly evolving field of positron emission tomography (PET) imaging has provided opportunities to investigate cancer's biological characteristics in vivo. This article reviews the current status of PET imaging on characterizing hallmarks of cancer and discusses the future directions of PET imaging strategies facilitating in vivo cancer phenotyping.